- Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
-
Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, Yang H
- KMID: 2374264
- J Gynecol Oncol.
- 2016 Nov;27(6):e62.
- doi: 10.3802/jgo.2016.27.e62
OBJECTIVE: Distal pancreatectomy with splenectomy may be required for optimal cytoreductive surgery in patients with epithelial ovarian cancer (EOC) metastasized to splenic hilum. This study evaluates the morbidity and treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer
-
Zwakman N, van de Laar R, Van Gorp T, Zusterzeel PL, Snijders M, Ferreira I, Massuger L, Kruitwagen RF
- KMID: 2413854
- J Gynecol Oncol.
- 2017 Jan;28(1):e7.
- doi: 10.3802/jgo.2017.28.e7
OBJECTIVE: In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We wanted to examine the relationship... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer
-
Lim MC, Yoo HJ, Song YJ, Seo SS, Kang S, Kim SH, Yoo CW, Park SY
- KMID: 2413432
- J Gynecol Oncol.
- 2017 Jul;28(4):e48.
- doi: 10.3802/jgo.2017.28.e48
OBJECTIVE: To investigate the survival outcomes in patients with bulky stage IIIC and IV ovarian cancer, treated by primary debulking surgery (PDS) and selective use of neoadjuvant chemotherapy (NAC) according... -
- CITED
-
- Close
- SHARE
-
- Close
